Tuesday, May 20, 2025

The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

General

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By Editorial Team

The FDA approves a new drug for HER2-positive gastric or gastroesophageal junction adenocarcinoma expressing PD-L1